🚀 VC round data is live in beta, check it out!
Ulisse Biomed Valuation Multiples
Discover revenue and EBITDA valuation multiples for Ulisse Biomed and similar public comparables like Merck KGaA, Illumina, Sartorius, Bio-Techne and more.
Ulisse Biomed Overview
About Ulisse Biomed
Ulisse Biomed SpA is a healthcare biotech company. It is engaged in developing medical diagnostics, theranostics, and therapeutics solutions. The company has three technology platforms, namely, Sagitta for molecular diagnostics, NanoHybrid for theranostics and diagnostics, and Aptavir for therapeutics.
Founded
2015
HQ
Employees
10
Website
Sectors
Financials (FY)
Market Cap
—
Ulisse Biomed Stock Performance
Ulisse Biomed has current market cap of —.
| Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|
| — | — | XXX | XXX | XXX | — |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialUlisse Biomed Valuation Multiples
Ulisse Biomed Financial Valuation Multiples
As of March 30, 2026, Ulisse Biomed has market cap of —.
Equity research analysts estimate Ulisse Biomed's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 |
|---|
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Ulisse Biomed Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Ulisse Biomed Public Comps
See public comps and valuation multiples for other Life Sciences Tools comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Merck KGaA | XXX | XXX | XXX | XXX | XXX | XXX |
| Illumina | XXX | XXX | XXX | XXX | XXX | XXX |
| Sartorius | XXX | XXX | XXX | XXX | XXX | XXX |
| Bio-Techne | XXX | XXX | XXX | XXX | XXX | XXX |
| Demant | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Ulisse Biomed M&A Activity
Ulisse Biomed acquired XXX companies to date.
Last acquisition by Ulisse Biomed was on XXXXXXXX, XXXXX. Ulisse Biomed acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Ulisse Biomed
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialUlisse Biomed Investment Activity
Ulisse Biomed invested in XXX companies to date.
Ulisse Biomed made its latest investment on XXXXXXXX, XXXXX. Ulisse Biomed invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Ulisse Biomed
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Ulisse Biomed
| When was Ulisse Biomed founded? | Ulisse Biomed was founded in 2015. |
| Where is Ulisse Biomed headquartered? | Ulisse Biomed is headquartered in Italy. |
| How many employees does Ulisse Biomed have? | As of today, Ulisse Biomed has over 10 employees. |
| Is Ulisse Biomed publicly listed? | Yes, Ulisse Biomed is a public company listed on Borsa Italiana. |
| What is the stock symbol of Ulisse Biomed? | Ulisse Biomed trades under UBM ticker. |
| When did Ulisse Biomed go public? | Ulisse Biomed went public in 2021. |
| Who are competitors of Ulisse Biomed? | Ulisse Biomed main competitors are Merck KGaA, Illumina, Sartorius, Bio-Techne. |
| Is Ulisse Biomed profitable? | No, Ulisse Biomed is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.